21 results
8-K
EX-1.1
Zymeworks Inc.
2 Aug 24
Entry into a Material Definitive Agreement
7:10am
), the exclusion law (42 U.S.C. § 1320a-7), all criminal laws relating to health care fraud and abuse, including without limitation 18 U.S.C. §§ 286, 287 … Protection and Affordable Care Act of 2010 (Public Law 111-148), as amended by the Health Care and Education Reconciliation Act of 2010 (Public Law 111
424B5
Zymeworks Inc.
2 Aug 24
Prospectus supplement for primary offering
7:00am
. Product liability claims may be brought against us or our strategic partners by participants enrolled in our clinical trials, patients, health care providers … of federal or state health care legislation or foreign regulations relating to the marketing, pricing and reimbursement of pharmaceutical products
424B5
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
. Product liability claims may be brought against us or our strategic partners by participants enrolled in our clinical trials, patients, health care providers … health care legislation or foreign regulations relating to the marketing, pricing and reimbursement of pharmaceutical products.
There have been U.S
424B5
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
in our clinical trials, patients, health care providers or others using, administering or selling any of our future approved products. If we cannot … to predict the future course of federal or state health care legislation or foreign regulations relating to the marketing, pricing and reimbursement
D
50c m7xe3b
3 Jan 24
$50.00 mm in equity / options / securities to be acquired, sold $50.00 mm, 2 investors
4:32pm
8-K
EX-10.1
2jpiz7yj
26 Dec 23
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
8:09am
424B5
a0fbv
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
g0psy1vrgjex2
8 May 23
Prospectus supplement for primary offering
5:18pm
8-K
EX-1.1
yru fqt7n12rhwvc35q
9 Nov 22
Entry into a Material Definitive Agreement
4:50pm
424B5
8h4t9ujbd8737y 988
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
im9 w54ns
8 Nov 22
Quarterly report
4:09pm
8-K
EX-1.1
eeya57t99wjd9jvuep
21 Oct 22
Entry into a Material Definitive Agreement
4:19pm
424B5
16j882p8
21 Oct 22
Prospectus supplement for primary offering
4:16pm